Lilly’s Eczema Drug Shows Durable Long-Term Response in Late-Stage Study
Eli Lilly said its eczema drug lebrikizumab (Ebglyss) showed durable long-term response in a late-stage study, with data highlighting sustained […]
Eli Lilly said its eczema drug lebrikizumab (Ebglyss) showed durable long-term response in a late-stage study, with data highlighting sustained […]
Sanofi has received a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) […]
There are events you attend and then there are platforms that change the way you see your industry. India Pharma […]
Biocon Limited has appointed Shreehas P. Tambe as its Chief Executive Officer and Managing Director, following the resignation of Siddharth […]
The US Food and Drug Administration (FDA) has approved Corcept Therapeutics’ relacorilant for the treatment of platinum-resistant epithelial ovarian cancer. […]
India’s pharmaceutical sector is not just growing, it’s leading globally, contributing nearly 60% of the world’s vaccines and rapidly advancing […]
China-based drugmaker Jiangsu Hengrui Pharmaceuticals reported quarterly profit below market estimates, impacted by pressure on its generic drug business. The […]
Novo Nordisk has reduced the price of its semaglutide-based weight-loss drug Wegovy in South Africa for the second time since […]
Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) […]
Gilead Sciences has announced plans to acquire Ouro Medicines in a deal valued at over $2 billion to expand its […]
As per the recent information, Kinny Singh has been appointed as Deputy Secretary in the Department of Pharmaceuticals under the […]
Akums Drugs & Pharmaceuticals Ltd. has announced the launch of Lasmiditan dispersible tablets, approved by the DCGI, for the acute […]
Strides Pharma Science Limited announced that its step-down subsidiary, Strides Pharma International AG (SPIAG), has entered into definitive agreements with […]